Published in Drug Week, May 18th, 2007
The new Pharmacor report Psoriatic Arthritis finds that although no drugs had been approved for treating the disease prior to 2002, the TNF-alpha inhibitors Enbrel, Remicade, and Humira have emerged over the past five years as highly effective treatments for psoriatic arthritis in the world's major...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.